These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24771481)

  • 1. Altered bone material properties in HLA-B27 rats include reduced mineral to matrix ratio and altered collagen cross-links.
    Gamsjaeger S; Srivastava AK; Wergedal JE; Zwerina J; Klaushofer K; Paschalis EP; Tatakis DN
    J Bone Miner Res; 2014 Nov; 29(11):2382-91. PubMed ID: 24771481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-B27 transgenic rats are susceptible to accelerated alveolar bone loss.
    Tatakis DN; Guglielmoni P
    J Periodontol; 2000 Sep; 71(9):1395-400. PubMed ID: 11022768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.
    Rauner M; Stupphann D; Haas M; Fert I; Glatigny S; Sipos W; Breban M; Pietschmann P
    J Rheumatol; 2009 Jan; 36(1):120-6. PubMed ID: 19040304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of bone strength in HLA-B27 transgenic rats is characterized by a high bone turnover and is mainly osteoclast-driven.
    Rauner M; Thiele S; Fert I; Araujo LM; Layh-Schmitt G; Colbert RA; Hofbauer C; Bernhardt R; Bürki A; Schwiedrzik J; Zysset PK; Pietschmann P; Taurog JD; Breban M; Hofbauer LC
    Bone; 2015 Jun; 75():183-91. PubMed ID: 25746795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated alveolar bone loss in HLA-b27 transgenic rats: an adult onset condition.
    Tatakis DN; Guglielmoni P; Fletcher HM
    J Rheumatol; 2002 Jun; 29(6):1244-51. PubMed ID: 12064843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased bone strength in HLA-B27 transgenic rat model of spondyloarthropathy.
    Akhter MP; Jung LK
    Rheumatology (Oxford); 2007 Aug; 46(8):1258-62. PubMed ID: 17526927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B27 rats develop osteopaenia through increased bone resorption without any change in bone formation.
    Papet I; El Yousfi M; Godin JP; Mermoud AF; Davicco MJ; Coxam V; Breuille D; Obled C
    J Musculoskelet Neuronal Interact; 2008; 8(3):251-6. PubMed ID: 18799858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated alveolar bone loss in male HLA-B27 transgenic rats: adult onset.
    May NY; Tatakis DN
    J Periodontal Res; 2004 Feb; 39(1):33-6. PubMed ID: 14687225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin.
    Bertrand V; Quéré S; Guimbaud R; Sogni P; Chauvelot-Moachon L; Tulliez M; Lamarque D; Charreire J; Giroud JP; Couturier D; Chaussade S; Breban M
    Eur Cytokine Netw; 1998 Jun; 9(2):161-70. PubMed ID: 9681392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased tissue protein synthesis during spontaneous inflammatory bowel disease in HLA-B27 rats.
    El Yousfi M; Breuillé D; Papet I; Blum S; André M; Mosoni L; Denis P; Buffière C; Obled C
    Clin Sci (Lond); 2003 Oct; 105(4):437-46. PubMed ID: 12793856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease.
    Hammer RE; Richardson JA; Simmons WA; White AL; Breban M; Taurog JD
    J Investig Med; 1995 Jun; 43(3):262-8. PubMed ID: 7614072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
    Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
    J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
    Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
    J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides.
    Milia AF; Ibba-Manneschi L; Manetti M; Benelli G; Messerini L; Matucci-Cerinic M
    Ann N Y Acad Sci; 2009 Sep; 1173():570-4. PubMed ID: 19758201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease Management.
    Blondeaux A; Valibouze C; Speca S; Rousseaux C; Dubuquoy C; Blanquart H; Zerbib P; Desreumaux P; Foligné B; Titécat M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease.
    Harnish DC; Albert LM; Leathurby Y; Eckert AM; Ciarletta A; Kasaian M; Keith JC
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G118-25. PubMed ID: 12958017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone mineral density in inflammatory bowel diseases in children].
    Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
    Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA; Hamdy NA
    Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The risk factor for low bone mineral density in patients with inflammatory bowel disease].
    Liu JB; Gao X; Zhang FB; Yang L; Xiao YL; Zhang RD; Li ZP; Hu PJ; Chen MH
    Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):833-6. PubMed ID: 20079225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.